DrugDashboards

Lacosamide

Lacosamide · LACOSAMIDE 200 mg/20mL · Solution · Oral · PAI Holdings, LLC dba PAI Pharma

NDC 00121-4048-95 · 1 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 20 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →

The short version

19 companies supply this market — deep enough that no single failure threatens the supply. The generic price is down 22% over the past year, to $0.0820 per mL. The brand (Vimpat) runs $2.30 per mL — 28× more. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0820per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$1.50per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal contracts pay (FSS)$1,066.79per package of 10X20MLGolden State Medical Supply, Inc. · Oct 31, 2025
  • Medicaid generic ceiling (FUL)$0.1752per MLweighted avg manufacturer price $0.1001 · Sep 1, 2024214% of what pharmacies pay — higher than 90% of drugs with this benchmark
  • List price (WAC, as filed)$980.50per packagePharmaceutical Associates Inc. · Dec 11, 2023

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Oct 2023Sep 2026$0.082
36 price points · per ML · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$1,077.57
Reported to Texas DSHS · 2026 annual filing · PAI Holdings LLC dba Pharmaceutical Associates, Inc. / PAI Pharma

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

8● Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • price down 23% year over year+8

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for lacosamide (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA216151
TE code
AA
Approval date
Aug 26, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Lacosamide (Solution)

LabelerStrengthFirst seenLast seen
Ajenat Pharmaceuticals LLCLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
American Health PackagingLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
ANI Pharmaceuticals, Inc.LACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.LACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Chartwell Governmental & Specialty RX, LLC.LACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Chartwell RX, LLCLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals LimitedLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Kanchan Healthcare IncLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Kesin Pharma CorporationLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Kesin Pharmaceutical CorporationLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Leading Pharma, LLCLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Major PharmaceuticalsLACOSAMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Major PharmaceuticalsLACOSAMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Novadoz Pharmaceuticals LLCLACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLACOSAMIDE 200 mg/20mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLACOSAMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLACOSAMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
PAI Holdings, LLC dba PAI PharmaLACOSAMIDE 150 mg/15mLJul 15, 2026Sep 2, 2026
Precision Dose, Inc.LACOSAMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Precision Dose, Inc.LACOSAMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
UCB, Inc.LACOSAMIDE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lacosamide — NDC 00121-4048-95," retrieved September 3, 2026, https://drugdashboards.com/drug/00121404895.

Free to cite with attribution — see how the data is put together.